真实世界证据解决方案市场规模、份额和成长分析（按组件、应用、收入模式、部署类型、最终用户和地区划分）—2026-2033年产业预测

全球真实世界证据 (RWE) 解决方案市场规模预计在 2024 年达到 18 亿美元，从 2025 年的 21 亿美元增长到 2033 年的 73.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 16.9%。

全球真实世界数据 (RWE) 解决方案在核准后安全性监测中已广泛应用，并加速融入药物研发生命週期，尤其是在药物疗效评估方面。许多国家正在利用 RWE 进行药物监测和上市后评估。政府的支持性政策和产业联盟的努力预计将进一步推动 RWE 应用领域的市场成长和创新。技术进步，特别是人工智慧 (AI) 和机器学习领域的进步，正在透过增强即时数据收集和分析能力来变革这一领域。这些技术能够从海量资料集中快速获取洞察，使研究人员和医疗保健专业人员能够识别真实世界资料中的模式和趋势。这有助于改善临床决策，并最终促进药物研发和患者照护效果的提升。

全球真实世界证据解决方案市场驱动因素

全球真实世界证据解决方案市场正受到人工智慧整合的显着推动，人工智慧使製药和生物技术公司能够更有效地产生有价值的真实世界证据。该技术简化了从各种资料来源（包括历史临床试验资料和真实世界资料集）中提取见解的流程。借助人工智慧驱动的分析和自动化，企业可以更全面地了解其研究，加快决策速度，并提高临床试验的整体效率。因此，人工智慧与真实世界数据的结合正在改变临床研究格局，并推动市场成长。

限制全球真实世界证据解决方案市场的因素

全球真实世界证据解决方案市场面临的一大挑战是缺乏能够运用新兴数位技术的合格专业人员。临床研究领域的这一人才缺口阻碍了先进数位解决方案在临床试验中的有效应用和实施。因此，它阻碍了产业发展，使各机构无法充分利用先进技术的潜力来提升研究能力和改善整体结果。解决此技能短缺问题对于市场的蓬勃发展以及最大程度地发挥真实世界证据解决方案的优势至关重要。

全球真实世界证据解决方案市场趋势

全球真实世界证据解决方案市场正呈现一个显着趋势：生命科学领域对全面资料利用的需求日益增长，推动了端到端服务需求的提升。相关人员致力于提供涵盖所有阶段的整合解决方案，从研究规划和通讯协定製定到管理和报告。这种综合方法使企业能够有效利用真实世界数据，在产品生命週期内做出明智的决策，从而促进从研发到商业化的平稳过渡。因此，这一趋势表明，效率、创新和策略洞察力正日益成为该领域的优先事项。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球真实世界证据解决方案市场规模（按组件和复合年增长率划分）（2026-2033 年）

• 服务
• 数据集
  • 异质资料集
  • 临床实践数据集
  • 计费资料集
  • 药房资料集
  • 患者主导资料集
  • 基于註册表的资料集
  • 集成资料集

全球真实世界证据解决方案市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 药物研发与核准
  • 肿瘤学
  • 循环系统疾病
  • 神经病学
  • 免疫学
  • 其他治疗领域
• 医疗设备开发和核准
• 上市后监测
• 市场进入/报销/保险范围决策
• 临床和监管决策

全球真实世界证据解决方案市场规模（按收入模式和复合年增长率划分）（2026-2033 年）

• 付费使用制（基于价值的定价）
• 订阅

全球真实世界证据解决方案市场规模（按部署模式和复合年增长率划分）（2026-2033 年）

• 本地部署
• 基于云端的

全球真实世界证据解决方案市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 医疗相关企业（製药、生物製药、医疗设备）
  • 临床研究
  • 商业的
  • HEOR
  • 其他的
• 医疗保险公司
• 医疗保健提供者
• 其他的

全球真实世界证据解决方案市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• IQVIA Holdings（USA）
• Syneos Health（USA）
• ICON plc（Ireland）
• Cognizant Technology Solutions Corporation（USA）
• Oracle Corporation（USA）
• SAS Institute Inc.（USA）
• Elevance Health Inc.（USA）
• Clinigen Group plc（UK）
• Cegedim Health Data（France）
• Verantos（USA）
• HealthVerity Inc.（USA）
• Datavant（USA）
• Syapse Inc.（USA）
• Tempus（USA）
• Flatiron Health（USA）
• PerkinElmer Inc.（USA）
• Trinity（USA）
• Aetion Inc.（USA）

结论与建议

Global Real-World Evidence Solutions Market size was valued at USD 1.80 Billion in 2024 and is poised to grow from USD 2.1 Billion in 2025 to USD 7.34 Billion by 2033, growing at a CAGR of 16.9% during the forecast period (2026-2033).

Global Real-World Evidence (RWE) solutions have seen significant adoption for post-approval safety surveillance and are increasingly integrated into the drug development lifecycle, particularly for assessing drug efficacy. Many countries leverage RWE for pharmacovigilance and post-marketing evaluations. Supportive government initiatives and industry coalitions are expected to further spur market growth and innovation in RWE applications. Technological advancements, particularly in Artificial Intelligence and Machine Learning, are transforming the field by enhancing real-time data collection and analysis. These technologies enable rapid insights from extensive datasets, allowing researchers and healthcare professionals to identify patterns and trends in real-world data. This leads to improved decision-making in clinical contexts, ultimately enhancing drug development and patient care outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Real-World Evidence Solutions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Real-World Evidence Solutions Market Segments Analysis

Global Real World Evidence Solutions Market is segmented by Component, Application, Revenue Model, Deployment Mode, End User and region. Based on Component, the market is segmented into Services and Data Sets. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Post-Market Surveillance, Market Access & Reimbursement/Coverage Decision-Making and Clinical & Regulatory Decision-Making. Based on Revenue Model, the market is segmented into Pay Per Use (Value-Based Pricing) and Subscription. Based on Deployment Mode, the market is segmented into On-Premise and Cloud-Based. Based on End User, the market is segmented into Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device), Healthcare Payers, Healthcare Providers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Real-World Evidence Solutions Market

The Global Real-World Evidence Solutions market is significantly propelled by the integration of artificial intelligence, which empowers pharmaceutical and biotech companies to enhance their generation of valuable real-world evidence. This technology streamlines the process of extracting insights from a variety of data sources, including historical clinical trial data and real-world datasets. By utilizing AI-driven analytics and automation, companies can achieve a more comprehensive understanding of their research, facilitating quicker decision-making and improving the overall effectiveness of clinical trials. As a result, the combination of AI and real-world data is transforming the landscape of clinical research, driving growth within the market.

Restraints in the Global Real-World Evidence Solutions Market

A significant challenge facing the Global Real-World Evidence Solutions market is the shortage of qualified professionals adept at navigating new digital technologies. This workforce gap within the clinical research sector hinders the effective adoption and implementation of sophisticated digital solutions in clinical trials. As a result, the industry's growth is stifled, as organizations struggle to leverage the full potential of advanced technologies that could enhance their research capabilities and improve overall outcomes. Bridging this skills deficit is crucial for the market to thrive and fully capitalize on the benefits offered by real-world evidence solutions.

Market Trends of the Global Real-World Evidence Solutions Market

The Global Real-World Evidence Solutions market is witnessing a notable trend towards the increasing demand for end-to-end services, driven by the need for comprehensive data utilization across the life sciences spectrum. Stakeholders are focusing on providing integrated solutions that encompass every stage, from study planning and protocol development to management and reporting. This holistic approach enables organizations to leverage real-world data effectively to make informed, evidence-based decisions throughout the entire lifecycle of a product, facilitating smoother transitions from research and development to commercialization. Consequently, this trend underscores the growing prioritization of efficiency, innovation, and strategic insights in the sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Real World Evidence Solutions Market Size by Component & CAGR (2026-2033)

• Market Overview
• Services
• Data Sets
  • Disparate Data Sets
  • Clinical Settings Data Sets
  • Claims Data Sets
  • Pharmacy Data Sets
  • Patient-Powered Data Sets
  • Registry-Based Data Sets
  • Integrated Data Sets

Global Real World Evidence Solutions Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Development & Approvals
  • Oncology
  • Cardiovascular Disease
  • Neurology
  • Immunology
  • Other Therapeutic Areas
• Medical Device Development & Approvals
• Post-Market Surveillance
• Market Access & Reimbursement/Coverage Decision-Making
• Clinical & Regulatory Decision-Making

Global Real World Evidence Solutions Market Size by Revenue Model & CAGR (2026-2033)

• Market Overview
• Pay Per Use (Value-Based Pricing)
• Subscription

Global Real World Evidence Solutions Market Size by Deployment Mode & CAGR (2026-2033)

• Market Overview
• On-Premise
• Cloud-Based

Global Real World Evidence Solutions Market Size by End User & CAGR (2026-2033)

• Market Overview
• Healthcare Companies (Pharmaceutical, Biopharmaceutical, Medical Device)
  • Clinical research
  • Commercial
  • HEOR
  • Others
• Healthcare Payers
• Healthcare Providers
• Others

Global Real World Evidence Solutions Market Size & CAGR (2026-2033)

• North America (Component, Application, Revenue Model, Deployment Mode, End User)
  • US
  • Canada
• Europe (Component, Application, Revenue Model, Deployment Mode, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Application, Revenue Model, Deployment Mode, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Application, Revenue Model, Deployment Mode, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Application, Revenue Model, Deployment Mode, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IQVIA Holdings (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant Technology Solutions Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS Institute Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elevance Health Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinigen Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cegedim Health Data (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verantos (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthVerity Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Datavant (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syapse Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aetion Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations